Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2018 Earnings Conference Call - Final Transcript
Apr 25, 2018 • 08:30 am ET
Peter J. Arduini
our adjusted EBITDA margins by about 100 basis points and grow adjusted earnings per share by over 20%. As I discussed earlier, Codman is a great deal and will serve as an important catalyst for Integra's global growth. The benefits for shareholders that we communicated are on track or exceeding the expectations that we had when we signed the deal over a year ago.
With the first quarter behind us, we're at an inflection point with our new commercial organizations substantially in place, a strong product pipeline and a team energized to move the company forward.
That concludes our prepared remarks. And operator, would you please open up our lines for questions.